These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 886853)

  • 21. The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons.
    Francavilla A; Jones AF; Benichou J; Starzl TE
    J Surg Res; 1980 Jan; 28(1):1-7. PubMed ID: 6244463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of portacaval anastomosis on glucose tolerance in the dog: evidence of an interaction between the gut and the liver in oral glucose dosposal.
    Lickley HL; Chisholm DJ; Rabinovitch A; Wexler M; Dupre J
    Metabolism; 1975 Oct; 24(10):1157-68. PubMed ID: 1165730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the concentrations of the large neutral amino acids in the brain and in the CSF of dogs after portacaval anastomosis.
    Jonung T; Ramzy A; Herlin P; Chance WT; James JH; Fischer JE
    HPB Surg; 1991; 4(4):299-312. PubMed ID: 1810372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.
    Smith AR; Rossi-Fanelli F; Ziparo V; James JH; Perelle BA; Fischer JE
    Ann Surg; 1978 Mar; 187(3):343-50. PubMed ID: 637594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of hepatic encephalopathy and alteration in amino acid profiles after blocking a surgical splenorenal shunt by interventional radiological techniques.
    Clarke B; Ellis MJ; Leung V; Hughes E; Meek JH; Allison DJ; Hodgson HJ
    J Hepatol; 1989 May; 8(3):325-9. PubMed ID: 2732446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic buffers in hepatic failure.
    Grossi CE; Prytz B; Rousselot LM
    Surgery; 1968 Nov; 64(5):928-33. PubMed ID: 5687843
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma amino acid, glucagon, and insulin concentrations in dogs with nitrosamine-induced hepatic disease.
    Strombeck DR; Harrold D; Rogers Q; Wheeldon E; Stern J; Schaeffer M
    Am J Vet Res; 1983 Nov; 44(11):2028-36. PubMed ID: 6359978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts.
    Hawkins PA; DeJoseph MR; Viña JR; Hawkins RA
    J Appl Physiol (1985); 1996 Mar; 80(3):885-91. PubMed ID: 8964752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin, ammonium, and glucose after portacaval shunting.
    Brown H; Covelli VH; Brown M
    Surgery; 1969 Aug; 66(2):383-91. PubMed ID: 5812419
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic inactivation of vasoactive intestinal peptide in man and dog.
    Ebeid AM; Escourrou J; Soeters PB; Murray P; Fischer JE
    Ann Surg; 1978 Jul; 188(1):28-33. PubMed ID: 666373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic effects of metabolic fuels on carbohydrate metabolism. I. Acute effect of elevation of plasma free fatty acids on hepatic glucose output, peripheral glucose utilization, serum insulin, and plasma glucagon levels.
    Seyffert WA; Madison LL
    Diabetes; 1967 Nov; 16(11):765-76. PubMed ID: 6072699
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration.
    Starzl TE; Porter KA; Putnam CW
    Metabolism; 1976 Nov; 25(11 Suppl 1):1429-34. PubMed ID: 790088
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypercholesterolaemia type II: changes in plasma insulin and glucagon levels after portacaval shunt.
    Farriaux JP; Luyckx AS; Ribet M
    J Inherit Metab Dis; 1980; 2(3):55-8. PubMed ID: 6796760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy.
    James JH; Ziparo V; Jeppsson B; Fischer JE
    Lancet; 1979 Oct; 2(8146):772-5. PubMed ID: 90864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.
    Starzl TE; Watanabe K; Porter KA; Putnam CW
    Lancet; 1976 Apr; 1(7964):821-5. PubMed ID: 56646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.